CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells
Philippe Gatault(Centre Hospitalier Universitaire de Tours), Christophe Baron(Université de Tours), Eloi Chevallier(Université de Tours), Catherine Gaudy‐Graffin(Université de Tours), Marie Piollet(Universitätsklinikum Würzburg), Gilles Thibault, Catherine S. Forconi(University of Massachusetts Chan Medical School), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Johan Noble(Université de Tours), Sally Al-Hajj(Université de Tours), Roxane Lemoine(Université de Tours), Matthias Büchler(Centre Hospitalier Universitaire de Tours), Elodie Miquelestorena‐Standley(Université de Tours)
Cited by 9
Related Papers
Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
|American Journal of Transplantation|2002|256
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228
Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population
|Kidney International|2000|191
Acute Renal Infarction
|Clinical Journal of the American Society of Nephrology|2012|176
Etiology and Outcomes of Thrombotic Microangiopathies
|Clinical Journal of the American Society of Nephrology|2019|167